Search Results - "Brito‐Dellan, Norman"
-
1
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Published in Cancer (01-10-2020)“…Background Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the…”
Get full text
Journal Article -
2
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
Published in Supportive care in cancer (01-10-2022)“…Cancer patients have an increased risk of developing venous thromboembolic events. Anticoagulation management includes prophylactic or therapeutic doses of low…”
Get full text
Journal Article -
3
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines
Published in Supportive care in cancer (01-05-2020)“…Purpose To update the clinical practice guidelines for the use of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the prevention and/or…”
Get full text
Journal Article -
4
Thrombosis, cancer, and COVID-19
Published in Supportive care in cancer (01-10-2022)“…Cancer and coronavirus disease 2019 (COVID-19) have unusual similarities: they both result in a markedly elevated risk of thrombosis, exceptionally high…”
Get full text
Journal Article -
5
Toxicities of the anti-PD-1 immune checkpoint antibody nivolumab in the acute inpatient setting
Published in Journal of clinical oncology (09-10-2016)“…Abstract only 227 Background: Knowledge of immune-system regulation led to the discovery of immune checkpoints molecules, which have demonstrated anti-tumor…”
Get full text
Journal Article -
6
Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review
Published in Supportive care in cancer (01-10-2022)“…This paper aims to provide a narrative review of the risks, diagnosis, and management of recurrent venous thromboembolism (VTE) in cancer patients. There is an…”
Get full text
Journal Article -
7
Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care
Published in Supportive care in cancer (01-10-2022)“…Central venous access devices (CVADs) including central venous catheters and peripherally inserted central catheters (PICCs) are essential in the treatment of…”
Get full text
Journal Article -
8
Complexity and clinical significance of drug-drug interactions
Published in Supportive care in cancer (01-10-2022)“…Cancer patients have an increased risk of developing venous thromboembolic events. Anticoagulation management includes prophylactic or therapeutic doses of low…”
Get full text
Journal Article -
9
Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
Published in Supportive care in cancer (01-10-2022)“…Thrombotic microangiopathy (TMA) is a syndrome that encompasses a group of disorders defined by the presence of endothelial damage leading to abnormal…”
Get full text
Journal Article -
10
Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm
Published in Journal of clinical oncology (01-06-2023)“…e18730 Background: Immune checkpoint inhibitor related pneumonitis (ICI-P) is one of the most frequent reasons for discontinuing immunotherapy. High mortality…”
Get full text
Journal Article -
11
Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm
Published in Supportive care in cancer (01-10-2024)“…Purpose Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a condition associated with high mortality, necessitating prompt recognition and treatment…”
Get full text
Journal Article -
12
Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e21054 Background: Immune checkpoint inhibitors (ICI) have gained success in the treatment of multiple malignancies including lung cancer…”
Get full text
Journal Article -
13
Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service
Published in Supportive care in cancer (01-03-2024)“…Purpose Immune checkpoint inhibitors (ICI) have become standard of care for some types of lung cancer. Along with expanding usage comes the emergence of…”
Get full text
Journal Article -
14
Opioid and Adjuvant Analgesics: Compared and Contrasted
Published in American journal of hospice & palliative medicine (01-08-2011)“…An adjuvant (or co-analgesic) is a drug that in its pharmacological characteristic is not necessarily primarily identified as an analgesic in nature but that…”
Get full text
Journal Article -
15
Utilizing electronic technologies to measure patient-reported outcomes (PRO) assessment completion time
Published in Journal of clinical oncology (09-10-2016)“…Abstract only 69 Background: Patient-reported outcomes (PROs) contribute to the assessment and treatment of cancer-related fatigue (CRF). Paper-based symptom…”
Get full text
Journal Article -
16
Safer transitions of care at a major cancer center: The emergency center to hospitalist experience
Published in Journal of clinical oncology (01-03-2016)“…Abstract only 247 Background: Failures in communication lead to serious medical errors particularly during transitions of care. A standardized handoff of…”
Get full text
Journal Article -
17
Meta-analysis: Risk of congestive heart failure (CHF) in selected targeted agents
Published in Journal of clinical oncology (10-10-2015)“…Abstract only 64 Background: Congestive heart failure (CHF) is among the most serious cardiovascular side effects of targeted agents (TA) impacting the…”
Get full text
Journal Article -
18
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study
Published in EClinicalMedicine (01-10-2024)“…Supportive care to ensure optimal quality of life is an essential component of cancer care and symptom control across the lifespan. Ongoing advances in cancer…”
Get full text
Journal Article -
19
Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center
Published in American journal of medical quality (01-11-2018)“…Communication failures during patient handoff can lead to serious errors. A quality improvement team created a standardized handoff tool/process (DE-PASS:…”
Get full text
Journal Article -
20
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study
Published in EClinicalMedicine (01-07-2024)“…Mucositis is a common and highly impactful side effect of conventional and emerging cancer therapy and thus the subject of intense investigation. Although…”
Get full text
Journal Article